# DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

> **NCT03718910** · — · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 15 (actual)

## Conditions studied

- DDX3X
- Mental Retardation, X-linked 102
- Autism Spectrum Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03718910
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-23
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718910, "DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03718910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*